Health & Medicine
- Health & Medicine
Down syndrome’s anti-tumor effect
The chromosomal abnormality that causes Down syndrome might protect against some solid tumors.
- Health & Medicine
Smoking ups risk for type 2 diabetes
Smoking increases the risk of developing type 2 diabetes by up to 61 percent.
- Health & Medicine
Addiction Alleviator? Hallucinogen’s popularity grows
The unsanctioned use of an obscure hallucinogen, ibogaine, to treat addiction has exploded recently.
- Health & Medicine
New Task: Malaria drug might inhibit some cancers
The antimalarial drug chloroquine may prevent some cancers.
- Health & Medicine
Keeping metabolic syndrome at bay
Chromium supplements reduced some of the unhealthy effects of a sedentary lifestyle in rats.
- Health & Medicine
A Different Side of Estrogen
Understanding estrogen's function is complicated by the fact that it can bind to two distinct receptors; scientists studying the second receptor now think that drugs targeting it could help a wide variety of ailments.
- Health & Medicine
Not Yet: CDC panel questions antidepressant gene test
A genetic test designed to tailor drug treatment for depression offers little clinical value, says a CDC panel.
- Health & Medicine
Unseen Risk: Lifestyle, physical problems may underlie psoriasis link to early mortality
Severe psoriasis knocks as many years off a person's expected life span as high blood pressure.
- Health & Medicine
It’s Spud Time
The United Nations wants more people to appreciate the potato's potential to fight world hunger.
- Health & Medicine
Immune cells to fight leukemia
A cancer vaccine against leukemia helps some patients avoid a relapse for months or years, but only if given early in the course of the disease or when a patient is in remission.
- Health & Medicine
In search of safer marrow transplants
A synthetic antibody called ACK2 that targets certain bone marrow cells may make marrow transplants a possibility for people with severe autoimmune disease.
- Health & Medicine
Novel fused protein quells inflammation
A new compound called GIFT-15, made from the fusion of two proteins, stops inflammation in mice.
